These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 9296322)
21. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460 [TBL] [Abstract][Full Text] [Related]
23. Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. Ekhart C; van Hunsel F; Scholl J; de Vries S; van Puijenbroek E Drug Saf; 2018 Jul; 41(7):677-683. PubMed ID: 29484612 [TBL] [Abstract][Full Text] [Related]
24. Serotonin Syndrome: Analysis of Cases Registered in the French Pharmacovigilance Database. Abadie D; Rousseau V; Logerot S; Cottin J; Montastruc JL; Montastruc F J Clin Psychopharmacol; 2015 Aug; 35(4):382-8. PubMed ID: 26082973 [TBL] [Abstract][Full Text] [Related]
25. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels. Elli C; Novella A; Pasina L Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391 [TBL] [Abstract][Full Text] [Related]
26. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
27. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238 [TBL] [Abstract][Full Text] [Related]
28. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase Nguyen TTH; Roussin A; Rousseau V; Montastruc JL; Montastruc F Drug Saf; 2018 Nov; 41(11):1087-1096. PubMed ID: 29956218 [TBL] [Abstract][Full Text] [Related]
29. Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders. Kling A; Danell-Boman M; Stenlund H; Dahlqvist R Arthritis Rheum; 2009 Oct; 61(10):1322-7. PubMed ID: 19790123 [TBL] [Abstract][Full Text] [Related]
30. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. Salkeld E; Ferris LE; Juurlink DN J Clin Psychopharmacol; 2008 Apr; 28(2):230-4. PubMed ID: 18344737 [TBL] [Abstract][Full Text] [Related]
32. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886 [TBL] [Abstract][Full Text] [Related]
33. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Gony M; Lapeyre-Mestre M; Montastruc JL; Clin Neuropharmacol; 2003; 26(3):142-5. PubMed ID: 12782916 [TBL] [Abstract][Full Text] [Related]
34. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Movig KL; Leufkens HG; Lenderink AW; Egberts AC Eur J Clin Pharmacol; 2002 May; 58(2):143-8. PubMed ID: 12012148 [TBL] [Abstract][Full Text] [Related]
35. Antidepressants and risk of cataract development: A population-based, nested case-control study. Chou PH; Chu CS; Chen YH; Hsu MY; Huang MW; Lan TH; Lin CH J Affect Disord; 2017 Jun; 215():237-244. PubMed ID: 28342338 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Spindelegger CJ; Papageorgiou K; Grohmann R; Engel R; Greil W; Konstantinidis A; Agelink MW; Bleich S; Ruether E; Toto S; Kasper S Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522416 [TBL] [Abstract][Full Text] [Related]
37. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths. Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533 [TBL] [Abstract][Full Text] [Related]
38. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. Janowsky DS; Shetty M; Barnhill J; Elamir B; Davis JM Int J Neuropsychopharmacol; 2005 Mar; 8(1):37-48. PubMed ID: 15482629 [TBL] [Abstract][Full Text] [Related]
39. Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study. Wang CY; Fu SH; Wang CL; Chen PJ; Wu FL; Hsiao FY Osteoporos Int; 2016 Jan; 27(1):57-63. PubMed ID: 26126579 [TBL] [Abstract][Full Text] [Related]
40. Association between antidepressant drug use and hyponatraemia: a case-control study. Movig KL; Leufkens HG; Lenderink AW; van den Akker VG; Hodiamont PP; Goldschmidt HM; Egberts AC Br J Clin Pharmacol; 2002 Apr; 53(4):363-9. PubMed ID: 11966666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]